Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease

Clinica Chimica Acta

Volumn 365, Issue 1-2, 2006, Pages 129-134

  Kostner, Karam M ^a   Fahti, Robert B ^a   Case, Colin ^a   Hobson, Peter ^b   Tate, Jil ^b   Marwick, Thomas H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Complement; Coronary syndromes; Endothelial function; Inflammation

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A;

ADULT; AGED; ARTICLE; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; VASCULAR ENDOTHELIUM;

AGED; COMPLEMENT ACTIVATION; CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 32044452429     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.08.028     Document Type: Article

References (32)

1. M. Yasuda, K. Takeuchi, and M. Hiruma The complement system in ischaemic heart disease Circulation 81 1990 156 163
2. K.M. Kostner Activation of the complement system: a crucial link between inflammation and atherosclerosis? Eur J Clin Invest 34 2004 800 802
3. R. Oksjoki, P. Kovanen, and M. Pentikainen Role of complement activation in atherosclerosis Curr Opin Lipidol 14 2003 477 482
4. J.C.K. Fitch, S. Rollins, and L. Matis Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with CPB Circulation 100 1999 2499 2506
5. M.J. Walport Complement. First of two parts N Engl J Med 344 2001 1058 1066
6. H.O. Madsen, V. Videm, A. Svejgaard, J.L. Svennevig, and P. Garred Association of mannose-binding lectin deficiency with severe atherosclerosis Lancet 352 1998 959 960
7. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
8. C.J. Packard, D.S. O'Reilly, and M.J. Caslake Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland coronary prevention study group N Engl J Med 343 2000 1148 1155
9. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
10. P.S. Seifert, and M.D. Kazatchine Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position Mol Immunol 24 12 1987 Dec 1303 1308
11. J. Torzewski, M. Torzewski, and D.E. Bowyer C-reactive protein frequently colocalizes with the terminal complement complex in early atherosclerotic lesions of human coronary arteries Arterioscler Thromb Vasc Biol 18 1998 1386 1392
12. T. Neunteufl, S. Heher, and R. Katzenschlager Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain Am J Cardiol 86 2 2000 207 210
13. R. Fathi, and T.H. Marwick Noninvasive tests of vascular function and structure: why and how to perform them Am Heart J 141 2001 694 703
14. D.S. Celermajer, K.E. Sorensen, and V.M. Gooch Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
15. R. Fathi, B. Haluska, N. Isbel, L. Short, and T.H. Marwick The relative importance of vascular structure and function in predicting cardiovascular events J Am Coll Cardiol 18;43 4 2004 616 623
16. H.M. Hoffmeister, R. Ehlers, and E. Buettcher Comparison of C-reactive protein and terminal complement complex in patients with unstable angina pectoris versus stable angina pectoris Am J Cardiol 90 10 2002 (Nov 15) 1168 1170
17. H. Yamashita, K. Shimada, E. Seki, H. Mokuno, and H. Daida Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris Am J Cardiol 91 2003 133 136
18. M. Griselli, J. Herbert, and W.L. Hutchinson C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction J Exp Med 190 12 1999 1733 1739
19. J. Torzewski, M. Torzewski, and D.E. Bowyer C-reactive protein frequently colocalizes with the terminal complement complex in early atherosclerotic lesions of human coronary arteries Arterioscler Thromb Vasc Biol 18 1998 1386 1392
20. G. Horstick, A. Heimann, and O. Goetze Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischaemia and reperfusion Circulation 95 1997 701 708
21. S. Taskinen, P.T. Kovanen, H. Jarva, S. Merti, and M.O. Pentikainen Binding of C-reactive protein to modified low-density lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein Biochem J 367 2002 403 412
22. S. Bhakdi, K.J. Lackner, S.R. Han, M. Torzewski, and M. Husmann Beyond cholesterol: the enigma of atherosclerosis revisited Thromb Haemost 91 4 2004 639 645
23. S.J. Cleland, N. Sattar, J.R. Petrie, N.G. Forouhi, H.L. Elliott, and J.M. Connell Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease Clin Sci (Lond) 98 2000 531 535
24. C.D. Stehouwer, M.A. Gall, J.W. Twisk, E. Knudsen, J.J. Emeis, and H.H. Parving Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death Diabetes 51 2002 1157 1165
25. S.M. Kang, N. Chung, and J.Y. Kim Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary artery disease Echocardiography 19 2002 661 667
26. S. Fichtlscherer, G. Rosenberger, D.H. Walter, S. Breuer, S. Dimmeler, and A.M. Zeiher Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease Circulation 102 2000 1000 1006
27. R. Kennedy, C. Case, R. Fathi, D. Johnson, N. Isbel, and T.H. Marwick Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease? Am J Med 110 2001 198 204
28. T.J. Anderson, A. Uehata, and M.D. Gerhard Close relation of endothelial function in the human coronary and peripheral circulations J Am Coll Cardiol 26 1995 1235 1241
29. K. Kostner, S. Hornykewyz, and P. Yang Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls Cardiovasc Res 1997 330 336
30. T. Neunteufl, K. Kostner, R. Katzenschlager, M. Zehetgruber, G. Maurer, and F. Weidinger Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men J Am Soc Cardiol 32 1998 711 716
31. T. Neunteufel, U. Priglinger, and S. Heher Effects of vitamin E on chronic and acute endothelial dysfunction in smokers J Am Coll Cardiol 35 2 2000 Feb 277 283
32. P.M. Ridker, C.P. Cannon, and D. Morrow C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28